Skip to main content
. 2016 Feb 25;11:391–397. doi: 10.2147/COPD.S100254

Table 1.

Baseline demographics of entire cohort and of completers and non-completers of pulmonary rehabilitation

Overall (n=440) PR completers (n=229) PR non-completers (n=211)
Age (years) 66.2 (9.0) 66.5 (9.0) 65.8 (9.1)
Sex, female, n (%) 179 (41) 91 (39.7) 88 (41.7)
Race
 Caucasian 317 (72) 165 (72) 152 (72)
 African American 76 (17) 42 (18) 34 (16)
 Other 47 (11) 22 (10) 25 (12)
BMI (m/kg2) 28.0 (7.5) 28.0 (7.3) 28.1 (7.7)
FEV1 (L)#,* 1.2 (0.6) 1.3 (0.6) 1.1 (0.6)
FEV1 % predicted# 44.2 (19.3) 46.3 (20.0) 42.3 (18.4)
FVC (L)# 2.5 (0.9) 2.4 (0.9) 2.6 (0.9)
Recent hospitalization, n (%) 178 (40.5) 88 (34.4) 90 (42.7)
Smoking status*
 Current 52 (11.8) 16 (7.0) 36 (17.3)
 Past 362 (82.3) 197 (86.8) 165 (79.3)
 Non 21 (4.8) 14 (6.2) 7 (3.4)
Smoking pack years 49.9 (42.3) 46.9 (42.2) 53.0 (42.2)
Home oxygen use, n (%) 220 (50) 117 (51.1) 103 (48.8)
Comorbidity index 2.2 (1.6) 2.1 (1.5) 2.3 (1.6)
Arthritis, n (%) 189 (43) 93 (40.6) 96 (45.5)
Coronary artery disease, n (%) 105 (23.9) 59 (25.8) 46 (21.8)
Congestive heart failure, n (%) 46 (10.5) 26 (11.4) 20 (9.5)
Cerebrovascular disease, n (%) 34 (7.7) 15 (6.6) 19 (9.0)
Peripheral vascular disease, n (%) 44 (10) 24 (10.5) 20 (9.5)
Dementia, n (%) 10 (2.3) 3 (1.3) 7 (3.3)
Depression, n (%) 91 (20.7) 46 (20.1) 45 (21.3)
Diabetes mellitus, n (%) 100 (22.7) 52 (22.7) 48 (22.7)
Hypertension, n (%) 277 (63) 141 (61.6) 136 (64.5)
Malignancy, n (%) 96 (21.8) 44 (19.2) 52 (24.6)
Obstructive sleep apnea, n (%) 50 (11.4) 29 (12.7) 10 (21)

Notes: All values are expressed as mean (standard deviation) unless otherwise specified.

#

Spirometry data available in 350 (80%) patients within 2 years prior to enrollment.

*

P<0.05 for comparisons between completers and non-completers.

Abbreviations: PR, pulmonary rehabilitation; BMI, body mass index; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity.